Filing Details
- Accession Number:
- 0001773751-24-000188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-12 16:33:26
- Reporting Period:
- 2024-06-10
- Accepted Time:
- 2024-06-12 16:33:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1965903 | Michael Chi | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-06-10 | 4,528 | $13.90 | 181,200 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-10 | 1,910 | $5.01 | 183,110 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-10 | 8,169 | $6.82 | 191,279 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-10 | 2,964 | $11.53 | 194,243 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-10 | 17,571 | $22.01 | 176,672 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-11 | 251,390 | $13.90 | 428,062 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-11 | 67,304 | $5.01 | 495,366 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-11 | 28,126 | $6.82 | 523,492 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-11 | 27,849 | $11.53 | 551,341 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-11 | 374,669 | $22.05 | 176,672 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 4,528 | $0.00 | 4,528 | $13.90 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 1,910 | $0.00 | 1,910 | $5.01 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 8,169 | $0.00 | 8,169 | $6.82 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-10 | 2,964 | $0.00 | 2,964 | $11.53 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-11 | 251,390 | $0.00 | 251,390 | $13.90 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-11 | 67,304 | $0.00 | 67,304 | $5.01 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-11 | 28,126 | $0.00 | 28,126 | $6.82 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-11 | 27,849 | $0.00 | 27,849 | $11.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 355,472 | 2031-05-27 | No | 4 | M | Direct | |
| 430,676 | 2032-02-24 | No | 4 | M | Direct | |
| 216,860 | 2032-08-10 | No | 4 | M | Direct | |
| 95,639 | 2033-03-01 | No | 4 | M | Direct | |
| 104,082 | 2031-05-27 | No | 4 | M | Direct | |
| 363,372 | 2032-02-24 | No | 4 | M | Direct | |
| 188,734 | 2032-08-10 | No | 4 | M | Direct | |
| 67,790 | 2033-03-01 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $22.00 - $22.10. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $22.00 - $22.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
Billionaire Hedge Funds
